Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Xenotransplantation|May 26, 2022
Pig-to-human kidney transplantation using brain-dead donors as recipients: One giant leap, or only one small step for transplantkind?Yoshikazu Ganchiku, Leonardo V Riella
Cell Transplantation|April 26, 2021
The Efficacy of the Hepatocyte Spheroids for Hepatocyte TransplantationKazuaki Shibuya, Masaaki Watanabe, Ryoichi Goto, et al.
Abdominal Radiology (New York)|June 30, 2026
Multimodal artificial intelligence models for liver fibrosis staging: a scoping reviewTakuto Yoshida, Yoh Asahi, Yoshikazu Ganchiku, et al.
Case Reports in Transplantation|May 31, 2022
Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell TransplantationKentaro Ichimura, Norio Kawamura, Ryoichi Goto, et al.
Immunity, Inflammation and Disease|January 22, 2022
The impact of preformed donor-specific antibodies in living donor liver transplantation according to graft volumeRyoichi Goto, Makoto Ito, Norio Kawamura, et al.
Frontiers in Pediatrics|May 14, 2023
Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantationRyoichi Goto, Yasutomo Fukasaku, Yoshikazu Ganchiku, et al.
Annals of Gastroenterological Surgery|July 7, 2023
Long-term risk of a fatty liver in liver donorsRyoichi Goto, Norio Kawamura, Masaaki Watanabe, et al.
Clinical Journal of Gastroenterology|May 31, 2022
Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantationReimi Suzuki, Ryoichi Goto, Norio Kawamura, et al.
Human Immunology|April 30, 2020
Novel immunological approach to asses donor reactivity of transplant recipients using a humanized mouse modelYasutomo Fukasaku, Ryoichi Goto, Yoshikazu Ganchiku, et al.
Immunohorizons|April 8, 2024
TCF1highPD-1+Ly108+CD8+ T Cells Are Associated with Graft Preservation in Sensitized Mice Treated with Non-Fc Receptor-Binding CD3 AntibodiesTakuji Ota, Ryoichi Goto, Takuya Harada, et al.
Pageof 2